Helix BioPharma Corp. (TSX:HBP)
Canada · Delayed Price · Currency is CAD 2.110
+0.130 (6.57%)
May 1, 2026, 3:59 PM EST
Helix BioPharma Market Cap
Helix BioPharma has a market cap or net worth of CAD 161.16 million as of May 1, 2026. Its market cap has increased by 277.87% in one year.
Market Cap
161.16M
Enterprise Value
161.49M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.11
Market Cap Chart
Since August 15, 1995, Helix BioPharma's market cap has increased from 9.38M to 161.16M, an increase of 1,617.48%. That is a compound annual growth rate of 9.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 161.16M | -10.97% |
| Dec 31, 2025 | 181.02M | 314.90% |
| Dec 31, 2024 | 43.63M | -4.12% |
| Dec 29, 2023 | 45.50M | 5.81% |
| Dec 30, 2022 | 43.00M | 0.61% |
| Dec 31, 2021 | 42.74M | -36.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Satellos Bioscience | 223.94M |
| ME Therapeutics Holdings | 75.12M |
| Sharp Therapeutics | 63.16M |
| Sernova Biotherapeutics | 59.65M |
| NurExone Biologic | 50.63M |
| Medicenna Therapeutics | 49.22M |
| Quantum BioPharma | 45.47M |
| Defence Therapeutics | 43.09M |